Results 251 to 260 of about 163,785 (367)
Impaired Aerobic Capacity and Physical Functional Performance in Older Heart Failure Patients With Preserved Ejection Fraction: Role of Lean Body Mass [PDF]
Mark J. Haykowsky+5 more
openalex +1 more source
Dapagliflozin alleviates high‐fat‐induced obesity cardiomyopathy by inhibiting ferroptosis
Abstract Aim: Dapagliflozin (Dapa) is a novel hypoglycaemic agent with multiple cardiovascular protective effects, and it is widely used in treatment of heart failure patients, but whether it can improve obese phenotype of heart failure and its mechanism is still unclear.
Di Chen+7 more
wiley +1 more source
Left atrioventricular coupling index measured by echocardiography in heart failure with preserved ejection fraction. [PDF]
Nguyen Ngoc Dang H+6 more
europepmc +1 more source
Sequeira et al. reveal how the glucagon‐like peptide‐1 receptor agonist (GLP‐1‐RA) semaglutide restores cardiomyocyte function in rats subjected to a high‐fat/high‐fructose diet (HFD). Employing fluorescence‐ and patch‐clamp technology in isolated cardiac myocytes, they demonstrate that semaglutide reverses HFD‐induced activation of L‐type calcium ...
Vasco Sequeira+12 more
wiley +1 more source
Comorbidities and incidence of heart failure with preserved ejection fraction: a systematic review and meta-analysis of cohort studies. [PDF]
Li L+6 more
europepmc +1 more source
Left ventricular volume regulation in heart failure with preserved ejection fraction [PDF]
Peter L. M. Kerkhof+3 more
openalex +1 more source
Abstract The main purpose of this project was to capture experts' opinion on hyperkalaemia management and form best practice recommendations for cardiorenal patients in Greece. A steering committee of nephrologists and cardiologists developed 37 statements. An online questionnaire completed by 32 experts in cardiorenal management in Greece.
Christina Chrysohoou+3 more
wiley +1 more source
Multi-microRNA diagnostic panel for heart failure with preserved ejection fraction in preclinical and clinical settings. [PDF]
Parvan R+8 more
europepmc +1 more source